|
home : | |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Customer List “R&D Manage is a sophisticated, flexible management
tool that allows us to identify, manage, and prioritize
resources by giving us the ability to track and forecast
by project as well as by overall P&L.” Our customers use R&D Manage and R&D Time as their corporate budgeting, forecasting and tracking solution. Each deployment is fully integrated with local accounting and payroll systems, and, in some cases, with purchasing and time reporting systems. Finance, management and project leaders use R&D Manage to proactively plan and measure the business performance of their respective areas of responsibility.
Roche Palo Alto
discovers and develops prescription drugs in key therapeutic areas
such as diseases of the nervous system, virology, infectious diseases,
oncology, cardiovascular diseases, inflammatory and autoimmune diseases,
dermatology, metabolic disorders and respiratory diseases.
Cytokinetics Inc.
is a new breed of cell-biology-driven biopharmaceutical company
focused on the discovery, development and commercializatio of next-generation
pharmaceuticals acting via novel mechanisms within pharmaceutically
validate cytoskeletal pathways.
Metabolex, Inc.
discovers and develops new drugs for type 2 diabetes and brings
to market novel drugs with distinct and complementary modes of action,
to address the full range of defects underlying diabetes.
Nuvelo, Inc.
formed by the merger of Hyseq Pharmaceuticals, Inc. and VARIAGENICS, Inc.,
is focused on the discovery and development of therapeutics that
improve life.
Pharmos Corporation
is a bio-pharmaceutical company focused on the discovery, development
and commercialization of therapeutics for the central and peripheral
nervous systems, and ophthalmologic, cardiovascular and inflammation-related
indications.
Neurogen Corporation
is a leader in both the discovery and development of new drug candidates
and in the development and integration of new drug discovery technologies,
most notably its AIDD (Accelerated Intelligent Drug Discovery) system.
Novacea, Inc.
is a rapidly growing drug development company that has the exclusive
worldwide rights to the Oregon Health & Science University (OHSU)
technology for dose and a method of use of calcitriol and its analogs,
potentially providing a major breakthrough in the treatment of cancer.
NPS Pharmaceuticals, Inc.
is engaged in the discovery and development of novel,
small molecule drugs and recombinant peptides that address a variety
of important diseases.
EPIX Pharmaceuticals, Inc.
's goal is to transform the management and diagnosis of vascular disease
through the development of targeted MRI contrast agents.
Avigen, Inc.
is commited to providing physicians and their patients with
innovative therapeutics for the treatment of neurological conditions.
Adamas Pharmaceuticals, Inc.
is developing superior neuroprotective medicines
for the treatment of central nervous system disorders.
Titan Pharmaceuticals, Inc.
(AMEX: TTP) is a biopharmaceutical company focused on the development and commercialization
of novel treatments for central nervous system disorders, cardiovascular disease,
bone disease and other disorders.
Intermune, Inc.
is a biopharmaceutical company focused on developing and commercializing
innovative therapies in pulmonology and hepatology.
Momenta Pharmaceuticals, Inc.
is a biotechnology company specializing in the detailed structural analysis
and design of complex sugars for the development of improved versions of existing drugs,
the development of novel drugs, and the discovery of new biological processes.
Alnylam Pharmaceuticals, Inc.
is a biopharmaceutical company developing novel therapeutics based on a breakthrough
discovery that enables the creation of a broad new class of human therapeutics.
SGX Pharmaceuticals, Inc.
is a biotechnology company focused on the discovery,
development and commercialization of innovative cancer therapeutics.
Zosano Pharma
is a spin-out of ALZA Corporation (a subsidiary of Johnson & Johnson).
The Macroflux system is based on a small patch and applicator that is intended to
provide a needle-free solution for transdermal delivery of therapeutic proteins, peptides and vaccines.
FivePríme Therapeutics, Inc.
is developing treatments for cancer and diabetes and multiple leads in metabolic and immunologic diseases, oncology and regenerative medicine.
Kalypsys, Inc.
is developing breakthrough therapies for some of the world's most widespread diseases
including cardiovascular/metabolic diseases, pain/inflammation and oncology.
Via Pharmaceuticals, Inc.
is a biotechnology company focused on the development of compounds for the
treatment of cardiovascular disease. Their drug development pipeline consists of both pre-clinical and
clinical-stage small molecule drugs that target various stages of vascular inflammation.
Catalyst Biosciences
is a leading biotechnology
company focused on developing proteases as a therapeutic platform for inflammation,
cardiovascular, and angiogenesis-based disorders.
Savient Pharmaceuticals, Inc.
is a specialty biopharmaceutical company engaged
in developing and distributing pharmaceutical products that target
unmet medical needs in both niche and broader markets.
Tercica, Inc.
is a biopharmaceutical company working to develop and commercialize
therapeutics for growth and other endocrine disorders.
Neurobiological Technologies, Inc.
is a biotechnology company engaged in the business of acquiring and developing central nervous
system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer.
Ambrx, Inc.
is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis
that enables the company to genetically engineer proteins with new amino acid building blocks beyond the
common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological
properties.
|
||||||||||||||||||||||||||
| home site map careers legal notices privacy policy | copyrights | |
